DV
Dividend Vision

ETON — Eton Pharmaceuticals, Inc.

Eton Pharmaceuticals, Inc. (ETON)

Total return is 841.8% over the past 7.8 years, 620.9 points ahead of SPY at 220.9%. Its deepest 1-year drawdown was 36.2%.

ETON is a healthcare equity stock focused on the pharmaceutical sector. As a single-stock holding rather than a diversified fund, it does not have a distribution rate or traditional expense ratio structure. This holding appeals primarily to investors seeking direct exposure to a specific pharmaceutical company rather than those focused on dividend income or broad diversification.

ETON key facts

Asset type
Stock
Asset class
Equity
Inception date
11/13/2018
Distribution frequency
None
Last close
$58.86
Market cap
$1,682,403,456
Average volume
2318188.0
Beta
0.869
Payout ratio
0.0
P/E ratio
150.9231
Forward P/E
49.505
EPS
$0.39